Optimizing Vascular Access in the Elderly: Words we Use Affect Patient Care

2015 ◽  
Vol 16 (6) ◽  
pp. 437-438 ◽  
Author(s):  
Ingemar Davidson ◽  
Maurizio Gallieni
2021 ◽  
pp. 112972982198990
Author(s):  
Kulli Kuningas ◽  
Nicholas Inston

Current international guidelines advocate fistula creation as first choice for vascular access in haemodialysis patients, however, there have been suggestions that in certain groups of patients, in particular the elderly, a more tailored approach is needed. The prevalence of more senior individuals receiving renal replacement therapy has increased in recent years and therefore including patient age in decision making regarding choice of vascular access for dialysis has gained more relevance. However, it seems that age is being used as a surrogate for overall clinical condition and it can be proposed that frailty may be a better basis to considering when advising and counselling patients with regard to vascular access for dialysis. Frailty is a clinical condition in which the person is in a vulnerable state with reduced functional capacity and has a higher risk of adverse health outcomes when exposed to stress inducing events. Prevalence of frailty increases with age and has been associated with an increased risk of mortality, hospitalisation, disability and falls. Chronic kidney disease is associated with premature ageing and therefore patients with kidney disease are prone to be frailer irrespective of age and the risk increases further with declining kidney function. Limited data exists on the relationship between frailty and vascular access, but it appears that frailty may have an association with poorer outcomes from vascular access. However, further research is warranted. Due to complexity in decision making in dialysis access, frailty assessment could be a key element in providing patient-centred approach in planning and maintaining vascular access for dialysis.


2017 ◽  
Vol 45 (6) ◽  
pp. 484-485 ◽  
Author(s):  
Miten J. Dhruve ◽  
Christopher T. Chan
Keyword(s):  

2006 ◽  
Vol 130 (5) ◽  
pp. 641-644 ◽  
Author(s):  
Virginia A. LiVolsi ◽  
Stanley Leung

Abstract Critical values in anatomic pathology are usually information sensitive, whereas most such values in laboratory medicine are time sensitive. However, there is an important time element in anatomic pathology as well. Pathologists should be aware that many medicolegal actions against radiologists are based on failure to communicate “abnormal” results in a timely manner. Are pathologists the next group that will be targeted? Pathologists can spend much time trying to communicate important data that will affect patient care to someone who will accept the information. This is not an efficient use of pathologists' professional time. Most important, what are our obligations to patients to communicate “critical” abnormal results to the treating physician? What results need to be so communicated? Are pathologists obliged to contact the patient directly if there is a failure to communicate the critical results to a clinician? We explore these questions to promote discussion of these important issues as they relate to pathologists' liability and to patient care.


2002 ◽  
Vol 20 (6) ◽  
pp. 563-568 ◽  
Author(s):  
Natalia Ridao-Cano ◽  
José R. Polo ◽  
Jorge Polo ◽  
Rafael Pérez-García ◽  
Mercedes Sanchez ◽  
...  
Keyword(s):  

2003 ◽  
Vol 8 (2) ◽  
pp. 8-13 ◽  
Author(s):  
Denise Macklin ◽  
Cynthia Chernecky ◽  
Katherine Nugent ◽  
Jennifer Waller

2016 ◽  
Vol 43 (2) ◽  
pp. 120-128 ◽  
Author(s):  
Hoon Suk Park ◽  
Woo Jeong Kim ◽  
Yong Kyun Kim ◽  
Hyung Wook Kim ◽  
Bum Soon Choi ◽  
...  

Background: Poor vessel quality and limited life expectancy in the elderly may make arteriovenous fistula (AVF) less ideal than arteriovenous graft (AVG) or catheter for vascular access (VA) in hemodialysis (HD). Methods: A total of 946 adult incident HD patients from clinical research center registry for end-stage renal disease prospective cohort in South Korea were analyzed for outcomes with AVF and AVG. Results: Overall, AVF was associated with better patient survival only in male (p < 0.001) and diabetic (p = 0.004) patients, although it was superior to AVG in access patency, regardless of diabetes mellitus status and gender. AVG (vs. AVF; hazard ratio (HR) 2.282; 95% CI 1.071-4.861; p = 0.032) was associated with poor patient survival. In elderly patients (≥65 years), AVF was associated with survival benefit only in male (p < 0.001) and diabetic (p = 0.04) patients, and with better access patency only in female (p = 0.05) and diabetic (p = 0.04) patients. AVG (vs. AVF; HR 3.158; 95% CI 1.080-9.238; p = 0.036) was associated with poor patient survival. In septuagenarian patients, AVF was associated only with survival benefit (p = 0.01) and there was no advantage in access patency (p = 0.12). However, AVF was superior to AVG in both access patency (p = 0.001) and patient survival (p = 0.03) even with propensity matching. Conclusion: AVF is the more desirable VA and its survival benefits warrant its consideration in septuagenarian patients although a prolonged life expectancy is essential to realize the potential benefits of AVF.


Sign in / Sign up

Export Citation Format

Share Document